Scrip Informa Pharma Intelligence
by Lucie Ellis
May 4, 2018
Data sharing initiative ATOM, of which GlaxoSmithKline is a member, wants to cut the time it takes to get from concept to molecule through comprehensive data sharing. John Baldoni, founder of ATOM and co-chair of its governing board, talks to Scrip about the consortium’s goals and bringing other big pharmas on board…
